Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 2/20 | 0.46 |
| ▸ | NPY4R | P50391 | 8/20 | 0.46 |
| ▸ | NPY1R | P25929 | 6/20 | 0.46 |
| ▸ | NPY5R | Q15761 | 5/20 | 0.46 |
| ▸ | GLP1R | P43220 | 4/20 | 0.46 |
| ▸ | SCTR | P47872 | 1/20 | 0.46 |
| ▸ | NPY2R | P49146 | 2/20 | 0.45 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.45 |
| ▸ | TUBB | P07437 | 1/20 | 0.45 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.45 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.45 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.45 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.45 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.45 |
| ▸ | TUBB2A | Q13885 | 1/20 | 0.45 |
| ▸ | TUBB8 | Q3ZCM7 | 1/20 | 0.45 |
| ▸ | TUBA3E | Q6PEY2 | 1/20 | 0.45 |
| ▸ | TUBA1A | Q71U36 | 1/20 | 0.45 |
| ▸ | TUBA1C | Q9BQE3 | 1/20 | 0.45 |
| ▸ | TUBB6 | Q9BUF5 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30845345 | 0.96 | NPY4R (0.47) | BACE1NPY4RNPY1RNPY5RGLP1R | |
| SCHEMBL30519216 | 0.94 | GLP1R (0.46) | BACE1NPY4RNPY1RNPY5RGLP1R | |
| SCHEMBL29519652 | 0.91 | NPY4R (0.54) | NPY4RNPY1RNPY5RGLP1RSCTR | |
| SCHEMBL29519643 | 0.90 | BACE1 (0.49) | BACE1NPY4RNPY1RNPY5RGLP1R | |
| SCHEMBL29958548 | 0.89 | NPY4R (0.49) | NPY4RNPY1RNPY5RNPY2RTUBB4A | |
| SCHEMBL29840375 | 0.89 | GLP1R (0.47) | BACE1NPY4RNPY1RNPY5RGLP1R | |
| SCHEMBL30612296 | 0.88 | NPY4R (0.54) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL29461968 | 0.88 | NPY4R (0.46) | NPY4RNPY1RNPY5RNPY2RTUBB4A | |
| SCHEMBL30152128 | 0.88 | NPY4R (0.47) | NPY4RNPY1RNPY5RNPY2RTUBB4A | |
| SCHEMBL29420164 | 0.88 | NPY4R (0.47) | NPY4RNPY1RNPY5RNPY2RTUBB4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230212222-A1 | COMPOSITION FOR ANTI-DIABETES AND ANTI-OBESITY COMPRISING NOVEL COMPOUND | ANYGEN CO., LTD. (KR) | 2023-07-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230212222-A1 | COMPOSITION FOR ANTI-DIABETES AND ANTI-OBESITY COMPRISING NOVEL COMPOUND | GPR119, GPR39, FABP4 | BACE1 2471/4885NPY4R 276/4885NPY1R 361/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.